NRC Health cash flow to debt ratio of 33.47% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

NRC Health's free cash flow has decreased -17.90% from $19.18M last year to $15.74M, signaling decreasing performance

NRC Health's debt to equity ratio is 13.75, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy

NRC Health's debt has increased relative to shareholder equity from 2.06 last year to 13.75 today, signaling weakened financials

NRC Health has a net debt to EBITDA ratio of 2.48x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

NRC Health's interest coverage ratio of 2.73 indicates that earnings with margin can cover interest payments on company debt

NRC Health's profit margin has decreased (-75.85%) in the last year from 17.32% to 4.18%, signaling decreasing performance

NRC Health's short-term liabilities of $36.62M exceed its short-term assets of $20.21M, signaling financial risk

NRC Health's return on assets of 4.30% is lower than the 5.00% threshold, indicating inefficient asset utilization

NRC Health's return on equity of 48.46%, is higher than 15.00%, indicating good performance

NRC Health's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

NRC Health had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings

NRC Health has positive free cash flow, indicating the company generates cash after capital expenditures

NRC Health has a free cash flow yield of 3.30%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

NRC Health's yearly earnings has decreased -53.19% since last year from $24.78M to $11.60M, signaling decreasing performance

NRC Health's yearly revenue has decreased -3.96% since last year from $143.06M to $137.39M, signaling decreasing performance

ROIC 8.75% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

NRC Health's 3-year revenue CAGR of -3.22% is negative, indicating declining revenue over the past 3 years

NRC Health had revenue growth in only 2.00 out of 5 years, indicating inconsistent revenue performance

NRC Health had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity

NRC Health is overvalued relative to its fair value price of 0.74 based on Discounted Cash Flow model

NRC Health has an earnings yield of 1.26%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

NRC Health is overvalued relative to its fair value price of 6.02 based on EBITDA multiple model

NRC Health has an EV/EBITDA ratio of 18.27x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

NRC Health is overvalued relative to its fair value price of 12.46 based on Earnings Fair Value model

NRC Health has no meaningful EPS growth rate; PEG ratio cannot be computed.

NRC Health has a price-to-book ratio of 71.20x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

NRC Health has a price-to-sales ratio of 3.33x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue